Key Takeaways
- Clinical Bottom Line
- The Failure of Surveillance
Clinical Bottom Line
| Root Cause of Interval Cancer | Endoscopic Source of Failure | Corrective Quality Measure |
|---|---|---|
| Missed Lesions (50-60%) | The physician literally drove past the adenoma without seeing it. | Optimize Adenoma Detection Rate (ADR) and mandate ≥ 6 minute withdrawal times. |
| Incomplete Resection (20%) | The lesion was found, but microscopic edges were left behind during piecemeal snaring. | Strict utilization of Cold Snare or En Bloc ESD techniques for complete margins. |
The Failure of Surveillance
The ultimate nightmare in gastroenterology is the “Interval Cancer”—a patient who undergoes a perfectly normal screening colonoscopy, is legally cleared for 10 years by the physician, but presents to the emergency room 3 years later with a massive, obstructing stage III colon adenocarcinoma. Analyzing these failures is paramount to reducing institutional liability.
The Biological vs. Mechanical Mismatch
While extremely rare cancers mutate aggressively fast, massive multi-center audits prove that the vast majority of interval cancers are iatrogenic (operator error). The primary culprit is the missed Sessile Serrated Lesion (SSL) hiding under a mucus cap in the right colon. When a physician aggressively rushes their withdrawal (completing the colonic evaluation in less than 4 minutes) or accepts a poor Boston Bowel Prep Score, they guarantee future interval cancers. In 2026, interval cancers are heavily audited, directly tying a physician’s historical Adenoma Detection Rate (ADR) to their malpractice risk.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
